Feasibility and Effectiveness of Respiratory Movement Management in Lung Cancer Receiving Stereotactic Radiotherapy Using a Novel Positional Fixation Device

ConditionLung Cancer, Non-Small Cell

Trial statusRecruiting

Trial phaseNot listed

Trial typeObservational

Biological sexAll

Age18+

SponsorTianjin Medical University Cancer Institute and Hospital

About this trial

The purpose of this clinical trial is to understand the safety and effectiveness of abdominal pressure devices in inhibiting respiratory movement in lung cancer patients. The main question it aims to answer is:

Did the abdominal pressure device reduce the respiratory movement of participants with lung cancer tumors?

Participants will:

Record how much they use abdominal pressure devices to suppress lung cancer tumor respiratory movement

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

None

Disqualifiers

None

Trial population

This trial will enroll 50 patients with NSCLC scheduled to receive SBRT

Trial design

Design model

Cohort

Time perspective

Prospective

Treatments tested in this trial

Chest and abdominal compression
Device
Abdominal compression suppresses respiratory movement in patients
breathing management
Device
Apply pressure to the patient's abdomen to achieve respiratory movement inhibition

Treatment groups

50 Participants

are divided into 2 treatment groups

Group A: Breathing management group2 interventions

Group B: No breathing management group0 interventions

Trial outcomes

Primary outcomes

Tumor displacement range

Based on 4DCT for delineating tumor motion range and extracting radiomics features in patients with and without respiratory management

Time frame

Within 6 months after enrollment

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

Tianjin Medical University Cancer Institute and Hospital

Lead sponsor

Source ClinicalTrials.gov

Apply now